Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T16:38:42.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T16:53:55.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The revision label on the Record History page updated from v3.6.6 to v3.7.0, signaling a new version of the page. This is a metadata update and does not modify the study data or its history.
    Difference
    0.1%
    Check dated 2026-09-19T19:32:56.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The history log now shows a new revision v3.6.6 added and the previous v3.6.5 removed, indicating a version update to the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:36:12.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.6.5, replacing the previous v3.6.4. This reflects a new build of the page's revision history rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-08T10:34:37.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.4) was added to the study history, replacing the previous version (v3.6.3) and documenting an updated version of the record.
    Difference
    0.1%
    Check dated 2026-07-25T04:37:08.000Z thumbnail image

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.